Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Teraa

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Platelets|November 26, 2016
The effect of P2Y12 inhibition on platelet activation assessed with aggregation- and flow cytometry-based assaysTesse C Leunissen, Peter Paul Wisman, Thijs C van Holten, et al.
Circulation|January 9, 2015
Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) trialMartin Teraa, Ralf W Sprengers, Roger E G Schutgens, et al.
APL Bioengineering|May 26, 2023
The effect of chronic kidney disease on tissue formation of <i>in situ</i> tissue-engineered vascular graftsPaul J Besseling, Merle M Krebber, Joost O Fledderus, et al.
Journal of Clinical Medicine|August 27, 2021
The Global Limb Anatomic Staging System (GLASS) for CLTI: Improving Inter-Observer AgreementJoep G J Wijnand, Devin Zarkowsky, Bian Wu, et al.
European Journal of Preventive Cardiology|April 8, 2024
Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM modelMarga A G Helmink, Sanne A E Peters, Jan Westerink, et al.
Communications Materials|July 21, 2025
Evaluation of in situ tissue-engineered arteriovenous grafts suitable for cannulation in a large animal modelPaul J Besseling, Wojciech Szymczyk, Martin Teraa, et al.
Advanced Healthcare Materials|March 7, 2024
Off-the-Shelf Synthetic Biodegradable Grafts Transform In Situ into a Living Arteriovenous Fistula in a Large Animal ModelPaul J Besseling, Wojciech Szymczyk, Martin Teraa, et al.
European Journal of Preventive Cardiology|July 6, 2023
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery diseasePascal M Burger, Jannick A N Dorresteijn, Aernoud T L Fiolet, et al.
European Heart Journal|May 2, 2025
Colchicine for secondary prevention of vascular events: a meta-analysis of trialsMarc-André d'Entremont, Michiel H F Poorthuis, Aernoud T L Fiolet, et al.
The British Journal of Surgery|April 17, 2025
Endovascular treatment of peripheral arterial disease: Endo-STAR framework for the design, conduct, and reporting of trialsEwa M Zywicka, Andrew J Moore, Christopher Twine, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Platelets|November 26, 2016
The effect of P2Y12 inhibition on platelet activation assessed with aggregation- and flow cytometry-based assaysTesse C Leunissen, Peter Paul Wisman, Thijs C van Holten, et al.
Circulation|January 9, 2015
Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) trialMartin Teraa, Ralf W Sprengers, Roger E G Schutgens, et al.
APL Bioengineering|May 26, 2023
The effect of chronic kidney disease on tissue formation of <i>in situ</i> tissue-engineered vascular graftsPaul J Besseling, Merle M Krebber, Joost O Fledderus, et al.
Journal of Clinical Medicine|August 27, 2021
The Global Limb Anatomic Staging System (GLASS) for CLTI: Improving Inter-Observer AgreementJoep G J Wijnand, Devin Zarkowsky, Bian Wu, et al.
European Journal of Preventive Cardiology|April 8, 2024
Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM modelMarga A G Helmink, Sanne A E Peters, Jan Westerink, et al.
Communications Materials|July 21, 2025
Evaluation of in situ tissue-engineered arteriovenous grafts suitable for cannulation in a large animal modelPaul J Besseling, Wojciech Szymczyk, Martin Teraa, et al.
Advanced Healthcare Materials|March 7, 2024
Off-the-Shelf Synthetic Biodegradable Grafts Transform In Situ into a Living Arteriovenous Fistula in a Large Animal ModelPaul J Besseling, Wojciech Szymczyk, Martin Teraa, et al.
European Journal of Preventive Cardiology|July 6, 2023
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery diseasePascal M Burger, Jannick A N Dorresteijn, Aernoud T L Fiolet, et al.
European Heart Journal|May 2, 2025
Colchicine for secondary prevention of vascular events: a meta-analysis of trialsMarc-André d'Entremont, Michiel H F Poorthuis, Aernoud T L Fiolet, et al.
The British Journal of Surgery|April 17, 2025
Endovascular treatment of peripheral arterial disease: Endo-STAR framework for the design, conduct, and reporting of trialsEwa M Zywicka, Andrew J Moore, Christopher Twine, et al.
Pageof 11